Medications for Acute Coronary Syndromes
KEYWORDS: patients, orally, risk, heparin, pci, day, used, hours, bleeding, given, nitroglycerin, therapy, coronary, use, acs

lipid levels (1). PCSK-9 inhibitors (evolocumab, alirocumab) are used for patients not at target low-density lipoprotein cholesterol levels. They are used alone or in combination with other lipid-lowering therapies (eg, statins, ezetimibe) for the treatment of adults with primary hyperlipidemia (including familial hypercholesterolemia). In patients who have had an MI, icosapent ethyl is also used to reduce lipid levels (2).
